REDHILL BIOPHARMA LTD. (RDHL) Revenue 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$8.0MFY2024 · since FY2015: $3,000 → $8.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $8.0M | +23.2% |
| FY2023 | $6.5M | -89.4% |
| FY2022 | $61.8M | -27.9% |
| FY2021 | $85.8M | +33.2% |
| FY2020 | $64.4M | +923.0% |
| FY2019 | $6.3M | -24.7% |
| FY2018 | $8.4M | +108.6% |
| FY2017 | $4.0M | +3867.3% |
| FY2016 | $101,000 | +3266.7% |
| FY2015 | $3,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice